Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 11/20 | 0.79 |
| ▸ | CDK2 | P24941 | 9/20 | 0.79 |
| ▸ | CCNE1 | P24864 | 4/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13305297 | 0.91 | CDK2 (0.77) | GSK3BCDK2 | |
| SCHEMBL12952876 | 0.88 | GSK3B (1.00) | GSK3BCDK2CCNE1 | |
| SCHEMBL13305338 | 0.88 | CDK2 (0.79) | GSK3BCDK2CCNE1CYP1A2CYP3A4 | |
| SCHEMBL13146269 | 0.88 | CDK2 (0.79) | GSK3BCDK2CCNE1 | |
| SCHEMBL12953190 | 0.85 | GSK3B (0.77) | GSK3BCDK2CCNE1 | |
| SCHEMBL13304831 | 0.85 | CDK2 (0.58) | GSK3BCDK2CCNE1CYP1A2CYP3A4 | |
| SCHEMBL13289158 | 0.85 | CDK2 (0.63) | GSK3BCDK2 | |
| SCHEMBL13305418 | 0.85 | CDK2 (0.63) | GSK3BCDK2CCNE1 | |
| SCHEMBL13305640 | 0.82 | CDK2 (0.54) | GSK3BCDK2CYP1A2CYP3A4 | |
| SCHEMBL12953496 | 0.82 | CDK2 (1.00) | GSK3BCDK2CCNE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1537116-B1 | PYRAZOLOPYRIMIDINES SUITABLE FOR THE TREATMENT OF CANCER DISEASES | SCHERING CORP (US) | 2010-06-02 | — | — | EP | disclosed |